| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
15,283 |
12,394 |
$1.28M |
| 99214 |
|
6,094 |
4,932 |
$369K |
| 99203 |
|
558 |
464 |
$56K |
| 99202 |
|
254 |
230 |
$32K |
| 99212 |
|
311 |
267 |
$31K |
| 36415 |
|
4,561 |
3,804 |
$7K |
| 96372 |
|
3,092 |
2,436 |
$6K |
| 90471 |
|
144 |
129 |
$6K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
435 |
389 |
$2K |
| 87880 |
|
2,901 |
2,286 |
$1K |
| 83036 |
|
117 |
107 |
$1K |
| 87804 |
|
2,169 |
1,146 |
$1K |
| 0012A |
|
68 |
67 |
$704.35 |
| 0011A |
|
89 |
79 |
$628.73 |
| 3078F |
|
5,760 |
4,441 |
$384.48 |
| 3079F |
|
2,287 |
1,717 |
$382.80 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
96 |
73 |
$355.38 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
27 |
14 |
$255.62 |
| 85025 |
|
55 |
53 |
$194.25 |
| 3077F |
|
3,433 |
2,577 |
$193.16 |
| 3008F |
|
8,547 |
6,508 |
$170.64 |
| 3080F |
|
1,100 |
810 |
$169.72 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
110 |
85 |
$165.49 |
| 3074F |
|
4,410 |
3,333 |
$143.95 |
| 90686 |
|
126 |
117 |
$130.16 |
| 0013A |
|
16 |
14 |
$107.61 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
616 |
425 |
$22.75 |
| 3075F |
|
1,515 |
1,165 |
$20.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
338 |
250 |
$6.72 |
| 1159F |
|
5,202 |
3,479 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
231 |
213 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
24 |
12 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
83 |
72 |
$0.00 |
| 1160F |
|
2,920 |
1,995 |
$0.00 |
| 81025 |
|
114 |
82 |
$0.00 |
| 1125F |
|
819 |
572 |
$0.00 |
| 91301 |
|
78 |
71 |
$0.00 |
| 1126F |
|
879 |
610 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
29 |
17 |
$0.00 |
| 90656 |
|
19 |
19 |
$0.00 |